Pipeline
Autifony’s pipeline includes clinical stage programmes for Fragile X and rare neurology and earlier stage programmes focused on Schizophrenia, Alzheimer’s Disease, Parkinson’s Disease, Fronto-Temporal Dementia and hearing loss
Compound | Indication | Lead Optimization | Preclinical Development | Phase I | Phase II |
---|---|---|---|---|---|
AUT00206 (Kv3.1/Kv3.2) | Fragile X Syndrome | ||||
AUT00201 (Kv3.1/Kv3.2) | Orphan Neurology | ||||
Kv3.1/3.2 modulators | Schizophrenia, Hearing Loss | ||||
Lysosomal Channel | Parkinson’s Disease | ||||
Novel Genetically linked Ion Channel | Alzheimer's Disease Frontotemporal Dementia |
Comments are closed.